Somnomed (ASX: SOM) — Perfil da empresa, notícias e dados financeiros
Somnomed is a medical technology company specializing in the design, development, manufacture, and commercialization of oral appliance therapy devices for treatment of obstructive sleep apnea and sleep-related breathing disorders.
Somnomed
Somnomed is a medical technology company specializing in the design, development, manufacture, and commercialization of oral appliance therapy devices for treatment of obstructive sleep apnea and sleep-related breathing disorders. Operating across 28 countries in North America, Europe, and the Asia-Pacific region, the company provides custom-made mandibular advancement devices as non-invasive, comfortable alternatives to continuous positive airway pressure therapy. Its products are manufactured to stringent medical device standards, serving sleep physicians, dentists, and patients globally. The business also produces bruxism nightguards and device cleaning solutions, having treated over one million patients worldwide since its establishment in 2004.
Resumo
Operações
Produtos e/ou serviços de Somnomed
- Mandibular Advancement Devices: Custom-fitted oral appliances engineered to gently move the lower jaw forward during sleep, maintaining an open upper airway for patients diagnosed with mild to moderate obstructive sleep apnea across North American, European, and Asia-Pacific healthcare markets.
- Digitally Designed Sleep Appliances: Precision-milled oral appliances fabricated using computer-aided design and manufacturing technology from digital dental impressions, delivering optimized anatomical fit, minimal bulk, and enhanced patient compliance as continuous positive airway pressure alternative treatments.
- Classic Mandibular Advancement Devices: Traditional acrylic oral appliances featuring dual-screw or strap-based titration mechanisms that allow sleep dentists to incrementally adjust lower jaw positioning for customized patient therapy across global clinical dental network distribution channels.
- Bruxism and Dental Protection Splints: Customized acrylic nightguards and splints designed to protect patient teeth against nocturnal grinding, clenching, and temporomandibular joint stress, distributed through dental practitioner networks to preserve dental structure alongside sleep therapy.
- Jaw Repositioning Accessories: Morning alignment devices prescribed to assist sleep apnea patients in restoring normal occlusal relationships and jaw posture after wearing overnight mandibular advancement appliances, minimizing bite changes and joint discomfort following sleep therapy.
- Appliance Hygiene and Maintenance Products: Specially formulated effervescent cleaning tablets and hygiene accessories designed for daily maintenance of oral medical devices, effectively removing bacteria and plaque without damaging proprietary acrylic or flexible liner material components.
equipe executiva do Somnomed
- Karen BorgCEO & Executive Director
- Ye-Fei GuoChief Financial Officer
- Greg KnightChief Operating Officer
- David LewisChief Information Officer
- Nathan MinnichChief Marketing Officer
- Janice Hiskett-JonesChief People Officer
- Marco Van KleefPresident of Europe
- Keshan GunasingheChief Product Officer
- Terence A. FlitcroftCompany Secretary
- Christopher BedfordVice President of Global Production and Product Development
Últimas notícias sobre a Somnomed
Comunicados recentes
O que a Somnomed (SOM) comunicou ao mercado, do mais recente para o mais antigo.
- Becoming a substantial holder
Principais indicadores financeiros
Resultados divulgados pela Somnomed, em AUD.
- Cap. de mercado
- 63,7 mi
- Receita (TTM)
- 114,5 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.0
- Dividend yield
- —
- Margem de lucro
- -2.3%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 114,5 mi | 976 mil | -2,7 mi | |
| 111,5 mi | 3,6 mi | -3,5 mi | |
| 91,7 mi | -8,3 mi | -12,2 mi | |
| 83,6 mi | -4,1 mi | -8 mi |